These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 22244024

  • 1. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
    Lertxundi U, Sanchez P, Hernandez R, Elizagarate E.
    J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
    [No Abstract] [Full Text] [Related]

  • 2. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
    Hazewinkel AW, Bogers JP, Giltay EJ.
    Gen Hosp Psychiatry; 2013 Dec; 35(5):576.e11-2. PubMed ID: 23395419
    [Abstract] [Full Text] [Related]

  • 3. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
    Joffe G, Eskelinen S, Sailas E.
    Am J Psychiatry; 2009 Feb; 166(2):236. PubMed ID: 19188296
    [No Abstract] [Full Text] [Related]

  • 4. Blood dyscrasias in clozapine-treated patients in Italy.
    Lambertenghi Deliliers G.
    Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
    [Abstract] [Full Text] [Related]

  • 5. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.
    Kolli V, Denton K, Borra D, Pulluri M, Sharma A.
    Psychooncology; 2013 Jul; 22(7):1674-5. PubMed ID: 23059755
    [Abstract] [Full Text] [Related]

  • 6. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S, Rosenius S, Spigset O.
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [Abstract] [Full Text] [Related]

  • 7. Use of cytokines in clozapine-induced agranulocytosis.
    Chin-Yee I, Bezchlibnyk-Butler K, Wong L.
    Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
    [Abstract] [Full Text] [Related]

  • 8. Clozapine, agranulocytosis, and benign ethnic neutropenia.
    Rajagopal S.
    Postgrad Med J; 2005 Sep; 81(959):545-6. PubMed ID: 16143678
    [No Abstract] [Full Text] [Related]

  • 9. As-Required Filgrastim for Late-Onset Neutropenia Complicating Long-Term Clozapine Treatment: a Case Report.
    Chan KSW, Lai NBW, Wong MMC, Pang PF.
    East Asian Arch Psychiatry; 2023 Mar; 33(1):28-31. PubMed ID: 36991553
    [Abstract] [Full Text] [Related]

  • 10. Lithium and clozapine-induced neutropenia/agranulocytosis.
    Blier P, Slater S, Measham T, Koch M, Wiviott G.
    Int Clin Psychopharmacol; 1998 May; 13(3):137-40. PubMed ID: 9690982
    [Abstract] [Full Text] [Related]

  • 11. Successful Use of Single Doses of Granulocyte-Colony Stimulating Factor (G-CSF) in the Treatment of Late-Onset Agranulocytosis Associated With Clozapine in a Patient With Treatment-Resistant Schizophrenia: A Case Report.
    Comacchio C, Dusi N, Lasalvia A.
    J Clin Psychopharmacol; 2016 Apr; 36(2):173-4. PubMed ID: 26859277
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of clozapine-induced agranulocytosis with recombinant granulocyte colony-stimulating factor.
    Gullion G, Yeh HS.
    J Clin Psychiatry; 1994 Sep; 55(9):401-5. PubMed ID: 7523362
    [Abstract] [Full Text] [Related]

  • 13. Haematological side effects of clozapine: patient characteristics.
    Miller PR, Cutten AE.
    N Z Med J; 1997 Apr 11; 110(1041):125-7. PubMed ID: 9140414
    [Abstract] [Full Text] [Related]

  • 14. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N, Gee S, Whiskey E, Taylor D, Mijovic A, Gaughran F, Shergill S, MacCabe JH.
    J Clin Psychiatry; 2015 Nov 11; 76(11):e1410-6. PubMed ID: 26646037
    [Abstract] [Full Text] [Related]

  • 15. Clozapine-induced agranulocytosis: a case report. Immunopathophysiological considerations.
    van de Loosdrecht AA, Faber HJ, Hordijk P, Uges DR, Smit A.
    Neth J Med; 1998 Jan 11; 52(1):26-9. PubMed ID: 9573739
    [Abstract] [Full Text] [Related]

  • 16. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
    Myles N, Myles H, Clark SR, Bird R, Siskind D.
    Aust N Z J Psychiatry; 2017 Oct 11; 51(10):980-989. PubMed ID: 28747065
    [Abstract] [Full Text] [Related]

  • 17. Association between clozapine-induced agranulocytosis and HLA subtyping.
    Lopez-Garcia P, Teresa Rodriguez J, De Castro P, Landecho I, Zapata R.
    J Clin Psychiatry; 2006 Oct 11; 67(10):1652-3. PubMed ID: 17107265
    [No Abstract] [Full Text] [Related]

  • 18. Clozapine re-challenge under the cover of Filgrastim.
    Gopalakrishnan R, Subhalakshmi TP, Kuruvilla A, Jacob KS.
    J Postgrad Med; 2013 Oct 11; 59(1):54-5. PubMed ID: 23525060
    [Abstract] [Full Text] [Related]

  • 19. Re: Cytokines and agranulocytosis induced by clozapine.
    Malek-Ahmadi P.
    Can J Psychiatry; 1996 Nov 11; 41(9):603. PubMed ID: 8946085
    [No Abstract] [Full Text] [Related]

  • 20. Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia.
    Mathewson KA, Lindenmayer JP.
    J Clin Psychopharmacol; 2007 Dec 11; 27(6):714-5. PubMed ID: 18004146
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.